Birchview Capital, LP Applied Therapeutics Inc. Transaction History
Birchview Capital, LP
- $95 Million
- Q2 2025
A detailed history of Birchview Capital, LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Birchview Capital, LP holds 280,000 shares of APLT stock, worth $406,000. This represents 0.09% of its overall portfolio holdings.
Number of Shares
280,000Holding current value
$406,000% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
78Shares Held
89.6MCall Options Held
152KPut Options Held
186K-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.7MShares$27.1 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY11.5MShares$16.7 Million0.19% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$16.4 Million4.26% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$11.3 Million1.64% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$9.53 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $69.6M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...